1. Home
  2. BGSF vs BEAT Comparison

BGSF vs BEAT Comparison

Compare BGSF & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BGSF Inc.

BGSF

BGSF Inc.

HOLD

Current Price

$4.46

Market Cap

49.1M

ML Signal

HOLD

BEAT

Heartbeam Inc.

HOLD

Current Price

$2.27

Market Cap

63.5M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGSF
BEAT
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
63.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BGSF
BEAT
Price
$4.46
$2.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.00
$6.75
AVG Volume (30 Days)
51.2K
30.8M
Earning Date
11-07-2025
11-13-2025
Dividend Yield
44.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$263,687,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
N/A
N/A
Revenue Growth
71.60
N/A
52 Week Low
$2.91
$0.54
52 Week High
$8.22
$3.48

Technical Indicators

Market Signals
Indicator
BGSF
BEAT
Relative Strength Index (RSI) 57.57 74.82
Support Level $4.25 $0.66
Resistance Level $4.66 $2.82
Average True Range (ATR) 0.22 0.26
MACD 0.01 0.18
Stochastic Oscillator 66.66 75.67

Price Performance

Historical Comparison
BGSF
BEAT

About BGSF BGSF Inc.

BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.

Share on Social Networks: